FAPI-PET/CT outperforms FDG-PET/CT in women with invasive breast cancer
AuntMinnie
MARCH 15, 2024
PET/CT imaging using gallium-68 (Ga-68) Fibroblast activation protein inhibitor (FAPI) radiotracer over F-18 FDG appears promising in women with invasive lobular carcinoma (ILC), according to a study published March 14 in the Journal of Nuclear Medicine. In an analysis of women diagnosed with ILC who underwent both imaging approaches, Ga-68 FAPI showed higher activity in tumors than F-18 FDG and identified more metastatic lesions, noted nuclear medicine physician and lead author Ertan Sahin, MD,
Let's personalize your content